The University of Freiburg in Germany, and a Japanese university have endorsed Tian Immunity Booster’s (TIB) ability to stop replication of HIV virus.
This follows research findings by Dr. Josef Schneider of Freiburg University.
Dr. Josef said results indicated that TIB attains almost 100 per cent inhibition of the HIV viral replication. The findings reveal that the fusion taking place between HIV and T-cell was almost 100 percent blocked, a clear sign that HIV viruses were being killed.
“The research has shown that TIB drugs are a combination of wide brand antibiotics and immunity boosters without any side effects and toxicity. This makes it the crucial base of TIB’s ability to fight HIV /Aids in Africa,” explained Josef in a research paper findings.
The immune booster was discovered by Professor Tian Shengxun, a Chinese herbal and medical researcher who lives in Kenya.